Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy, Volume 4 (Hardcover)

Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.

General

Imprint:	Academic Press Inc
Country of origin:	United States
Series:	Cancer Sensitizing Agents for Chemotherapy
Release date:	November 2018
First published:	2019
Series editors:	Benjamin Bonavida
Volume editors:	Zhe-Sheng Chen • Dong-Hua Yang
Dimensions:	235 x 191 x 18mm (L x W x T)
Format:	Hardcover
Pages:	292
ISBN-13:	978-0-12-816435-8
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Chemotherapy
LSN:	0-12-816435-2
Barcode:	9780128164358

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!